title: Disruption of endothelial cell interactions with the novel HU177 cryptic collagen epitope inhibits angiogenesis.
abstract: OBJECTIVE
  The importance of cellular communication with the extracellular matrix in regulating cellular invasion is well established. Selective disruption of communication links between cells and the local microenvironment by specifically targeting non-cellular matrix-immobilized cryptic extracellular matrix epitopes may represent an effective new clinical approach to limit tumor-associated angiogenesis. Therefore, we sought to determine whether the HU177 cryptic collagen epitope plays a functional role in regulating angiogenesis in vivo.
  
  
  METHODS
  We examined the expression and characterized the HU177 cryptic collagen epitope in vitro and in vivo using immunohistochemistry and ELISA. We examined potential mechanisms by which this cryptic collagen epitope may regulate angiogenesis using in vitro cell adhesion, migration, proliferation, and biochemical assays. Finally, we examined the whether blocking cellular interactions with the HU177 cryptic epitope plays a role in angiogenesis and tumor growth in vivo using the chick embryo model.
  
  
  RESULTS
  The HU177 cryptic epitope was selectively exposed within tumor blood vessel extracellular matrix, whereas little was associated with quiescent vessels. An antibody directed to this cryptic site selectively inhibited endothelial cell adhesion, migration, and proliferation on denatured collagen type IV and induced increased levels of cyclin-dependent kinase inhibitor p27(KIP1). Systemic administration of mAb HU177 inhibited cytokine- and tumor-induced angiogenesis in vivo.
  
  
  CONCLUSIONS
  We provide evidence for a new functional cryptic regulatory element within collagen IV that regulates tumor angiogenesis. These findings suggest a novel and highly selective approach for regulating angiogenesis by targeting a non-cellular cryptic collagen epitope.
authors.affiliation: Department of Radiation Oncology, The New York University Cancer Institute, New York University School of Medicine, New York, New York 10016, USA.
authors.forename: Alexandra
authors.initials: A
authors.lastname: Cretu
authors.forename: Jennifer M
authors.initials: JM
authors.lastname: Roth
authors.forename: Maresa
authors.initials: M
authors.lastname: Caunt
authors.forename: Abebe
authors.initials: A
authors.lastname: Akalu
authors.forename: Desiree
authors.initials: D
authors.lastname: Policarpio
authors.forename: Silvia
authors.initials: S
authors.lastname: Formenti
authors.forename: Paul
authors.initials: P
authors.lastname: Gagne
authors.forename: Leonard
authors.initials: L
authors.lastname: Liebes
authors.forename: Peter C
authors.initials: PC
authors.lastname: Brooks
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000494:pharmacology; D001681:Biological Assay; D002448:Cell Adhesion / Q000187:drug effects; D049109:Cell Proliferation / Q000187:drug effects; D002642:Chick Embryo; D024141:Collagen Type IV / Q000276:immunology / Q000378:metabolism*; D050760:Cyclin-Dependent Kinase Inhibitor p27 / Q000378:metabolism; D004730:Endothelium, Vascular / Q000187:drug effects / Q000378:metabolism*; D000939:Epitopes / Q000276:immunology / Q000378:metabolism*; D005109:Extracellular Matrix / Q000378:metabolism*; D006801:Humans; D009369:Neoplasms / Q000098:blood supply; D009389:Neovascularization, Pathologic / Q000209:etiology* / Q000378:metabolism; D015854:Up-Regulation
chemical_list: D000911:Antibodies, Monoclonal; D024141:Collagen Type IV; D000939:Epitopes; D050760:Cyclin-Dependent Kinase Inhibitor p27